Moreover, an analysis of 44 pediatric T-ALL samples showed that 21 out of 44 patients displayed mutations along the PI3K/Akt signaling pathway, and those with complete loss of PTEN correlated with a poor clinical outcome (chemotherapy induction failure) [65]. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.